Veterinärmedizinische Universität Wien Forschungsinformationssystem VetDoc

Rebuzzi Laura,

Beiträge für wissenschaftliche Veranstaltungen

Vortrag

Willmann, M; Gabner, S; Reifinger, M; Rebuzzi, L; Tichy, A; Thalhammer, JG; Selzer, E (2009): Immunohistochemical detection of vascular endothelial growth factor (VEGF) and c-kit (CD117) in canine melanoma. 233-233.-19th ECVIM-CA Congress; SEP 8-10, 2009; Porto, PORTUGAL.

Hadzijusufovic, E; Rebuzzi, L; Gleixner, KV; Vales, A; Kondo, R; Gruze, A; Kneidinger, M; Krauth, MT; Samorapoompichit, P; Greish, K; Mayerhofer, M; Pickl, WF; Maeda, H; Willmann, M; Valent, P (2008): Identifi cation of heat shock protein (Hsp32) as a novel therapeutic target in neoplastic mast cells. ESVONC autumn meeting, Budapest, Hungary, 13–15 September, 2007. Vet Comp Oncol (6), 1 84-85.

Hadzijusufovic, E; Rebuzzi, L; Gleixner, KV; Vales, A; Konto, R; Gruze, A; Kneidinger, M; Krauth, MT; Samorapoompichit, P; Greish, K; Mayerhofer, M; Pickl, WF; Maeda, H; Willmann, M; Valent, P (2008): Identification of Heat Shock Protein 32 (Hsp32) as a Novel Target in Canine Mastocytoma Cells. 28-29.-4th PhD Symposium, Medical University of Vienna; MAY 28-29, 2008; Vienna, AUSTRIA.

Sekis, I; Gerner, W; Willmann, M; Rebuzzi, L; Thalhammer, JG; Saalmüller, A; Kleiter, M (2008): Radiation does not enhance vascular endothelial growth factor (VEGF) expression in the canine mastocytoma cell line C2. 54-54.-1st World Vet Cancer Congress / 1st ESVONC/VCS joint meeting; Feb 28 - Mar 1, 2008; Kopenhagen, DENMARK.

Willmann, M; Gabner, S; Nagy, K; Reifinger, M; Rebuzzi, L; Thalhammer, JG; Erovic, B; Selzer, E (2008): Immunohistochemical detection of epidermal growth factor (EGFR) Type I in canine melanoma. 191-191.-18th ECVIM-CA Congress; SEP 4-6, 2008; Ghent, BELGIUM.

Hadzijusufovic, E; Rebuzzi, L; Gleixner, KV; Vales, A; Kondo, R;Gruze, A; Kneidinger, M;Krauth, MT; Samorapoompichit, P; Greish, K; Mayerhofer, M; Pickl, WF; Maeda, H; Willmann, M; Valent, P (2007): Identification of Heat Shock Protein (Hsp32) as a Novel Therapeutic Target in Neoplastic Mast Cells. 194--17th ECVIM-CA Congress; Sep 13-15, 2007; Budapest, HUNGARY.

Sekis, I; Willmann, M; Rebuzzi, L; Gerner, W; Käser, T; Thalhammer, JG; Saalmüller, A; Kleiter, M (2007): Radiation Enhances Vascular Endothelial Growth Factor (Vegf) Expression In The Canine Mastocytoma Cell Line C2. -European Society Of Veterinary Oncology, Spring Meeting.; März 23-25, 2007; Cambridge, UK.

Shibly, S; Haderer, A; Rebuzzi, L (2007): Akuter letaler Liquidothorax bei einem Hundewelpen mit Parvovirusenteritis und chronischer fibrinös-eitriger Pleuritis. -22th VÖK-Annual Congress; SEP 22-23, 2007; Salzburg, AUSTRIA .

Willmann, M; Rebuzzi, L; Sonneck, K; Gleixner, K; Florian, S; Kondo, R; Mayerhofer, M; Gruze, A; Pickl, WF; Valent, P (2007): Detection of VEGF and VEGF receptors in canine mastocytomas. Mast Cell Symposium, AKH; Mai 2-3, 2007; Vienna, AUSTRIA. 2007.

Rebuzzi, L; Sonneck, K; Agis, H; Vales, A; Kondo, R; Mayerhofer, M; Gruze, A; Pickl, WF; Willmann, M; Valent, P (2006): Expression of vascular endothelial growth factor (VEGF) and its receptors VEGFR-1 (Flt-1) and VEGFR-2 (KDR) in neoplastic mast cells. 23--ESVONC Spring Meeting; Apr 1-2, 2006; Slovenia.

Rebuzzi, L; Sonneck, K; Agis, H; Vales A; Kondo, R; Mayerhofer, M; Gruze, A; Pickl, WF; Willmann, M; Valent, P (2006): Identification of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR in canine neoplastic mast cells. -ÖGHO Frühjahrstagung; APR 27-29, 2006; Wels, AUSTRIA.

Rebuzzi, L; Willmann, M; Sonneck, K; Gleixner, KV; Florian, S; Kondo, R; Mayerhofer, M; Vales, A; Gruze, A; Pickl, WF, Thalhammer JG; Valent, P (2006): Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cells. -XXV EAACI Congress 2006; JUN 10-14, 2006; Vienna, AUSTRIA.

Rebuzzi, L; Sonneck, K; Agis, H; Vales, A; Thalhammer, JG; Willmann, M; Valent, P (2005): Phenotypic and functional characterization of the C2 dog mastocytoma cell line. 76-77.-Annual Meeting of the Austrian Society for Allergology and Immunology (ÖGAI); DEC 1-3, 2005; Vienna, AUSTRIA.

Rebuzzi, L; Sonneck, K; Agis, H; Vales, A; Willmann, M; Valent, P (2005): Immunophenotypic characterization and target profile of the canine mastocytoma cell line C2. -25th Annual VCS Conference; OCT 20-23, 2005; Huntington Beach, USA.

Poster

Hadzijusufovic, E; Peter, B; Rebuzzi, L; Gleixner, KV; Gruze, A; Kneidinger, M; Thaiwong, T; Pickl, WF; Yuzbasiyan-Gurkan, V; Willmann, M; Valent, P (2009): Antiproliferative Effects of Four Tyrosine Kinase Inhibitors on Neoplastic Feline Mast Cells Exhibiting a kit Exon-8 ITD Mutation. 267-267.-19th ECVIM-CA Congress; SEP 8-10, 2009; Porto, PORTUGAL.

Hadzijusufovic, E; Peter, B; Rebuzzi, L; Baumgartner, C; Gleixner, KV; Gruze, A; Kneidinger, M; Pickl, WF; Willmann, M; Valent (2008): Identification of the Tyrosine Kinase Receptor Kit as a Molecular Target in Neoplastic Ferline Mast Cells. 98-98.-28th Annual VCS Conference; OCT 18-21, 2008; Seattle, USA.

Hadzijusufovic, E; Peter, B; Rebuzzi, L; Baumgartner, C; Gleixner, KV; Gruze, A; Kneidinger, M; Pickl, WF; Willmann, M; Valent, P (2008): Evaluation of growth-inhibitory effects of kit tyrosine kinase inhibitors on feline neoplastic mast cells. 215-215.-18th ECVIM-CA Congress; SEP 4-6, 2008; Ghent, BELGIUM.

Hadzijusufovic, E; Peter, B; Rebuzzi, L; Baumgartner, C; Gleixner, KV; Gruze, A; Kneidinger, M; Pickl, WF; Willmann, M; Valent, P (2008): Antiproliferative Effects of KIT Tyrosine Kinase Inhibitors in Feline Neoplastic Mast Cells. Frühjahrstagung 2008 der Österreichischen Gesellschaft für Hämatologie und Onkologie und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich (AHOP), Innsbruck, Austria, APR 10-12, 2008. Magazine of European Medical Oncology (1), Suppl. 1 10-10.

Hadzijusufovic, E; Rebuzzi, L; Gleixner, KV; Vales, A; Kondo, R; Gruze, A; Kneidinger, M; Krauth, MT; Samorapoompichit, P; Greish, K; Mayerhofer, M; Pickl, WF; Maeda, H; Willmann, M; Valent, P (2007): Identification of Heat Shock Protein 32 (Hsp32) as a Novel Target in Canine Mastocytoma Cells. ÖGHO und AHOP Frühjahrstagung, Vienna, AUSTRIA, Apr 12-14, 2007 . Wiener medizinische Wochenschrift / Supplement (157), 121 16.

Hadzijusufovic, EH; Rebuzzi, L; Gleixner, KV; Vales, A; Kondo, R; Gruze, A; Kneidinger, M; Krauth, MT; Samoorapoompichit, P; Greish, K; Mayerhofer, M; Pickl, WF; Hiroshi, M; Willman, M; Valent, P (2007): Identification of heme oxygenase-1 (HO-1=Hsp32) as a novel therapeutic target in canine mastocytoma cells. 12th Congress of the European Hematology Association, Vienna, Austria, June 7 – 10, 2007 . Haematol-Hematol J (92) 489-490.

Rebuzzi, L; Willmann, M; Sonneck, K; Gleixner, KV; Florian, S; Kondo, R; Mayerhofer, M; Vales, A; Gruze, A; Pickl, WF; Thalhammer, JG; Valent, P (2006): Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cells. .-26th Annual VCS Conference; OCT 19-22, 2006; Georgia, USA.

© Veterinärmedizinische Universität Wien Hilfe und Downloads